biological activity | Fatostatin (125B11) is a derivative of diarylthiazole, Sterol regulatory element binding proteins (SREBPs) specific inhibitors of activation. Fatostatin binds to SCAP (srebbp cleavage-activating protein) and inhibits ER-Golgi translocation of SREBPs. Fatostatin can inhibit the growth of cancer cells and enhance the apoptosis of cancer cells. |
Target | Value |
Cell Line:
| DU-145 cells |
Concentration:
| 0.1, 1 μM |
Incubation Time:
| 3 days |
Result:
| Impaired the IGF1-induced growth at an IC 50 of 0.1 μM. Blocked increases in body weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under uncontrolled food intake. |
Animal Model:
| Four-to-five-week-old homozygous male obese ( ob/ob ) mice (C57BL/6J) |
Dosage:
| 30 mg/kg; 150 μL |
Administration:
| i.p. injection; daily for 28 days |